Biotech Stock News (OREX) (TKPHF) (VRTX) (PBYI)

Orexigen Therapeutics (NASDAQ:OREX)  On May 12, 2015 Shares of Orexigen tanked by 13% after the company reported that the cardiovascular outcome study had to be terminated early. The “LIGHT” study recruited up to 9,000 patients to determine if patients taking Contrave have an increased risk of cardiovascular issues. The mess up occurred because the early … Read more

Biotech Stock News (OREX) (ABBV) (PCYC) (GILD) (OHRP)

Orexigen Therapeutics (OREX) Shares of Orexigen Therapeutics were up 40% on 3/3/15 when the company announced that early safety data showed that Contrave was not only safe to take but in addition it was able to reduce a patient’s risk of generating cardiovascular health issues such as a heart-attack. Contrave was approved by the FDA … Read more

Orexigen (OREX) Stock Falling Hard As FDA Speaks Out

Recently we discussed an announcement made by Orexigen (OREX) bring heart benefits of their diet pill Contrave to the public. The story was simple. Orexigen (OREX) held a study to find out whether or not Contrave caused any increase in chances of heart attack and heart disease. Through the course of the study, the group … Read more

Orexigen (OREX) Stock Climbs | Diet Pill Has Hidden Heart Benefits

Recently, Terry Chrisomalis has started contributing articles in the BioTech space that really peaked my interest. So, I decided to go digging around in BioTech to see what all the buzz was about. That brought me to Orexigen (OREX). Orexigen Therapeutics is an American pharmaceutical company that recently discovered hidden heart benefits in the oddest … Read more